Stay updated with breaking news from John haurum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Share this article Share this article COPENHAGEN, Denmark, April 29, 2021 /PRNewswire/ Adcendo, a biotech company developing antibody-drug conjugates (ADCs) for the treatment of cancers, today announced the successful closing of a EUR 51 million (US$ 62 million) Series A financing. The investment was led by Novo Seeds, the early-stage investment and company creation team of Novo Holdings, and Ysios Capital, along with RA Capital Management, HealthCap and Gilde Healthcare. The company was initially incubated and funded at the BioInnovation Institute (BII). The new financing, which is the largest Series A financing for a Danish biotech company, will be used to establish a pipeline of ADCs directed at novel cancer targets and to bring the lead program targeting the novel cancer target uPARAP/Endo180 to proof of concept in patients. ....
Get the latest industry news first when you subscribe to our daily newsletter. We will never sell or share your information without your consent. See our privacy policy. ....
Adcendo raises EUR 51 Million in Series A Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Cancers prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Notice of Saniona AB annual shareholders meeting April 23, 2021 The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. The shareholders in Saniona AB, Reg. No. 556962-5345, are hereby invited to the annual shareholders meeting ( Sw . In light of the ongoing Covid-19 pandemic and in order to reduce the risk of infection spreading, the board of directors has resolved that the annual shareholders meeting will be held only by advance voting (postal vote) in accordance with temporary legislation. This means that the annual shareholders meeting will be conducted without the physical presence of shareholders, proxies or external parties and that shareholders exercise of voting rights at the annual shareholders meeting can only take place by advance shareholders voting in the order prescribed below. Information on the resolutions passed by the annual sha ....
Election of auditor. Resolution on guidelines for remuneration to senior executives. Resolution on authorization for the board of directors regarding issues. Closing of the meeting. Item 1: Election of Chairman of the meeting Shareholders together representing approximately 20 per cent of the shares and votes in the company (the “Proposers”) propose that lawyer Ola Grahn is elected as chairman of the meeting or, in his absence, the person appointed by the board of directors instead. Item 2: Preparation and approval of the register of voters The register of voters that is proposed to be approved is the register of voters prepared by the company, based on the share register of the meeting and received advance votes, controlled by the person confirming the minutes of the meeting. ....